Changes of antimicrobial resistance among clinical isolates of Escherechia coil in Shanghai 1990-2004

National Medical Journal of China

Volumn 86, Issue 1, 2006, Pages 12-16

  Zhang, Ying Yuan ^a   Zhu, De Mei ^a   Wu, Shi ^a   Wang, Fu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Drug resistance; Escherechia coli; Microbial; Microbial susceptibility testing

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE INHIBITOR; CEFACLOR; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; CHLORAMPHENICOL; GENTAMICIN; IMIPENEM; NITROFURANTOIN; PIPERACILLIN; QUINOLONE DERIVATIVE; TETRACYCLINE;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CHINA; DRUG SENSITIVITY; ESCHERICHIA COLI; HOSPITAL INFECTION; NONHUMAN;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHINA; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 31144464937     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Mandell GL, Bennett JE, Raphael D, eds. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, London: Churchill Livingstone,2000. 821-856,2299-2301.
2. Gordon KA, Jones RN. SENTRY participant groups. Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America: results from the SENTRY antimicrobial surveillance program (2000). Diagn Microbiol Infect Dis,2003, 45:295-301.
3. Beidenbach DJ, Moet GJ, Jones RN. Pathogen occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY antimicrobial surveillance program(1997-2000). Diag Microbial Infect Dis,2004,50:59-69.
4. Paterson DL, Rossi F, Baquero F, et al. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 study for monitoring antimicrobial resistance trends (SMART). J Antimicrob Chemother,2005, 55: 965-973.
5. Hoban DJ, Biedenbach DJ, Mutnick AH, et al. Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY antimicrobial surveillance study(2000). Diagn Microbiol Infect Dis, 2003, 45:279-285.
6. Streit J, Jones RN, Sader HS, et al. Assessment of pathogen occurrence and resistance profiles among infected patients in the intensive care unit: report from the SENTRY antimicrobial surveillance program (North America, 2001). Int J Antimicrob Agents,2004, 24:111-118.
7. Wang H, Chen MJ. Surveillance for antimicrobial resistance among clinical isolates of Gram-negative bacteria from intensive care unit patients in China, 1996 to 2002. Diagn Microbiol Infect Dis, 2005, 51:201-208.
8. Chinese source. 2004,27:38-45.
9. Chinese source. 2005,5:4-12.
10. Xiong ZZ, Zhu DM, Wang F, et al. Investigation of extended-spectram β-lactamase in Klebsiellae pneumoniae and Escherichia coli from China. Diagn Microbiol Infect Dis,2002,44:195-200.
11. Chinese source. 2002,27:177-180.
12. Chinese source. 1997,24:30-32.
13. Hooper DC. New uses for new and old quinolones and the challenge of resistance. Clin Infect Dis,2000, 30:243-254.
14. Liton AH. Animal to man transmission of enterobacteriaceae. Royal society of health Journal, 1997,97:115-118.
15. WHO. Use of quinolones in food animals and potential impact on human health. WHO/EMC/IDI/98. 10.
16. Wang MG, Tran JH, Jacoby GA, et al. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother,2003,47:2242-2248.